Search for: "In re: Abbott Laboratories" Results 41 - 60 of 237
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jan 2011, 9:52 am by Rebecca Tushnet
Lacey, Division Counsel, Abbott Laboratories I came in near the end, but Lacey emphasized that a marketer needs to know the difference between labeling (FDA authority) and other material (FTC)—if you detail to pediatricians about foods with nutritional benefits, for example, FDA largely prohibits nutrient claims for kids under 2. [read post]
11 Sep 2023, 4:00 am by Administrator
Canadian Securities Law Canadian Class Actions MonitorSaskatchewan Court of Appeal: Serial Certification Attempts Abusive In Abbott Laboratories, Ltd. v Spicer, the Saskatchewan Court of Appeal permanently stayed a proposed class action that was the last of five proposed national class actions concerning the drug sibutramine. [read post]
28 Apr 2022, 4:17 pm by Coral Beach
On another occasion product was not re-called from the market even after management became aware of a nonconformity (“NC”). [read post]
9 Sep 2008, 12:06 am
"Swanson's (aka Abbott's) Case: Abbott Laboratories ("Abbott") licensed Swanson's patent, and sued Syntron Bioresearch, Inc. for infringement. [read post]
30 Aug 2017, 12:00 pm by Dan Goodin
Like many wireless devices, pacemakers from Abbott Laboratories contain critical flaws that allow hijackers within radio range to seize control while the pacemakers are running. [read post]
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
14 Aug 2014, 5:14 am by Jon Hyman
Deborah Malin worked in the IT department of the Abbott Laboratories’s hospital product division (spun off to a new company, Hospira, in 2006). [read post]
3 Jun 2022, 9:30 am by Bill Marler
Here are the whistleblower documents – Redacted Confidential Disclosure re Abbott Laboratories – 10-19-2021_Redacted (1) Here is the 2022 inspection report at the plant – Updated Final Applied_Unapplied Redactions Abbott Nutrition Sturgis FEI 1815692 FDA 483 1-31022 to 3-16-22 – ISSUED_Redacted Here is the complaint – abbott_complaint_0 Here is the consent decree – abbott_proposed_consent_decree_0 Please read… [read post]